Filing Details
- Accession Number:
- 0001144204-13-006436
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-02-06 16:08:45
- Reporting Period:
- 2013-02-04
- Filing Date:
- 2013-02-06
- Accepted Time:
- 2013-02-06 16:08:45
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1426800 | Ventrus Biosciences Inc | VTUS | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1374805 | H Russell Ellison | 99 Hudson Street 5Th Floor New York NY US 10013 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-02-04 | 9,376 | $2.52 | 9,376 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2013-02-05 | 5,624 | $2.59 | 15,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options (right to buy) | $8.10 | 2022-01-15 | 60,000 | 60,000 | Direct | |
| Common Stock | Stock Options (right to buy) | $6.00 | 2020-12-22 | 573,599 | 573,599 | Direct | |
| Common Stock | Warrants (right to buy) | $7.69 | 2014-11-08 | 8,065 | 8,065 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2022-01-15 | 60,000 | 60,000 | Direct |
| 2020-12-22 | 573,599 | 573,599 | Direct |
| 2014-11-08 | 8,065 | 8,065 | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.51 to $2.52, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.51 to $2.59, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
- The options vest 1/3 on 1/15/2013, and the remaining 2/3 will vest in equal installments on the first and second anniversaries after 1/15/2013.
- The options vested 1/3 on 12/22/2010, and the remaining 2/3 will vest in equal installments on the first and second anniversaries after 12/22/2010.
- The warrant vested in three installments on 3/21/2008 (2,689 shares), 3/21/2009 (2,688 shares) and 3/21/2010 (2,688 shares).
Billionaire Hedge Funds
